Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News

What’s Going On With Palantir Technologies Today?

By Nabaparna Bhattacharya
April 25, 7:55 AM
Palantir Technologies (PLTR) shares dip premarket despite multi-year partnership with Parexel to enhance clinical trials efficiency using AI platforms.

PLTR

Read More
1 minute read
  • Biotech
  • Exclusives
  • General
  • Health Care
  • Market-Moving Exclusives
  • News
  • Top Stories

EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes

By Vandana Singh
April 25, 7:45 AM
Unlock the potential of adaptive immunity with ImmuneSelect by Virax Biolabs. Investigate T-Cell driven immunity for post-viral syndromes like Long COVID. Explore peptide pools and recombinant antibodies for immune profiling.

VRAX

Read More
2 minute read
  • Equities
  • General
  • Markets
  • News

Trump’s Social Media Company Auditor Misspells Own Name 14 Times In Regulatory Filings: Report

By Benzinga Neuro
April 25, 7:37 AM
Such spelling inconsistencies are not common among auditors.

DJT

Read More
2 minute read
  • General
  • Markets
  • News
  • Tech

Japanese Automakers Toyota, Nissan Partner With Tencent, Baidu To Boost AI Capabilities In China

By Benzinga Neuro
April 25, 7:27 AM
The alliance aims to capitalize on Tencent's expertise in big data, AI, and cloud computing.

BIDU

Read More
1 minute read
  • Equities
  • General
  • Markets
  • Movers
  • News

What’s Going On With HashiCorp Shares After Getting Takeover Deal From IBM?

By Nabaparna Bhattacharya
April 25, 6:21 AM
HashiCorp shares are trading higher in the premarket session on Thursday, while International Business Machines shares are slumping.

HCP

Read More
2 minute read
  • General
  • Markets
  • News

Amazon Pauses Green Card Sponsorship For Foreign Workers In 2024 Amid Layoffs: Report

By Benzinga Neuro
April 25, 6:16 AM
Amazon first put a halt to PERM applications in 2023.

AMZN

Read More
2 minute read
  • Equities
  • General
  • Large Cap
  • M&A
  • Media
  • Movers
  • News

World’s Largest Miner BHP Bids To Takeover Anglo American As Hunt For Resources Intensify

By Shivani Kumaresan
April 25, 5:30 AM
BHP makes a bold move, initiating a bid for Anglo American. Anglo disclosed receiving an unsolicited merger proposal. This deal could redefine the mining landscape, establishing the world's top copper producer and attracting industry competitors.

AAUKF

Read More
2 minute read
  • Analyst Color
  • Equities
  • General
  • Markets
  • Tech

To Lower Or Not? EV Pricing Dilemma Hampers Ford’s Profitability, Warns Analyst

By Benzinga Neuro
April 25, 4:46 AM
This could pose a significant challenge for automakers like Ford Motor Company (NYSE: F) in achieving profitability in the EV sector.

F

Read More
2 minute read
  • General
  • News
  • Tech

Warren Buffet-Backed BYD Takes On Luxury EV Market With New Premium Sedan, Posing Direct Challenge For Mercedes-Benz

By Benzinga Neuro
April 25, 2:44 AM
This development follows Mercedes-Benz reducing its stake in their joint premium EV venture from 50% to 10%.

BYDDF

Read More
1 minute read
  • Biotech
  • General
  • News

Sensei Biotherapeutics To Present Topline Clinical Data From The SNS-101 Phase I Dose Escalation Study At The 2024 ASCO Annual Meeting

By Benzinga Newsdesk
April 24, 4:52 PM
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that topline clinical

SNSE

Posts pagination

Previous 1 … 167 168 169 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service